Find an Eye MD near you!

This retrospective review shows that the introduction of corneal collagen crosslinking may have reduced the number of keratoplasty procedures for keratoconus.

The FDA has issued a final guidance document for industry and FDA staff on minimally invasive glaucoma surgical (MIGS) devices.

Ocular Therapeutix announced promising topline results from a phase 2 clinical trial of sustained-released dexamethasone for inflammatory dry eye disease.

Retrospective review shows anti-VEGF treatment should be performed cautiously in patients with retinal angiomatous proliferation (RAP).

Embattled drugmaker Valeant Pharmaceuticals has struck a deal with Walgreens to distribute some of its drugs at a 10% discount.

Mundipharma and Purdue Pharma Canada have acquired marketing rights to Merck’s glaucoma portfolio outside of the United States.